Working… Menu

Rehabilitation by Effort for Patients With Advanced Bronchial Cancer (RehabKBP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03684486
Recruitment Status : Recruiting
First Posted : September 25, 2018
Last Update Posted : July 30, 2020
Information provided by (Responsible Party):
University Hospital, Toulouse

Brief Summary:

Bronchopulmonary cancers or mesothelioma are associated with effort deconditioning due to pathology (chronic inflammation) and also to treatments (surgery, radiotherapy, chemotherapy); it's considerably alters patients quality of life.

Investigators want to ensured the feasibility of rehabilitation by effort for these patients.

Condition or disease Intervention/treatment Phase
Bronchial Cancer Malignant Mesothelioma Behavioral: rehabilitation by effort Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Rehabilitation by Effort for Patients With Advanced Bronchial Cancer
Actual Study Start Date : February 1, 2012
Estimated Primary Completion Date : February 1, 2021
Estimated Study Completion Date : February 1, 2022

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: rehabilitation by effort
8 sessions of rehabilitation by effort in sports medicine
Behavioral: rehabilitation by effort

Primary Outcome Measures :
  1. patients who completed at least 6 sessions of rehabilitation [ Time Frame: 10 years ]
    number of patients who completed at least 6 sessions of rehabilitation by effort

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • General condition according to World Health Organisation 0-1
  • Age between 18 and 70 years old
  • Non progressive patients according to RECIST criteria 1.1 after chemotherapy treatment whichever line of treatment
  • Autonomous patient
  • Voluntary written informed consent signed
  • Patients with social security insurance

Exclusion Criteria:

  • Bone metastasis with fracture risk
  • Significant cardiovascular pathology
  • Cardiac, vascular, rheumatologic or neurologic contraindication
  • Patients living far 60 kms from Toulouse
  • Patients under juridical protection guardianship, or tutelage measure

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03684486

Layout table for location contacts
Contact: Julien MAZIERES, MD PhD 05 67 77 18 37 ext +33

Layout table for location information
CHU de Toulouse Recruiting
Toulouse, France, 31059
Contact: Julien MAZIERES, PhD         
Sponsors and Collaborators
University Hospital, Toulouse
Layout table for investigator information
Principal Investigator: Julien Mazières, MD PhD University Hospital, Toulouse
Layout table for additonal information
Responsible Party: University Hospital, Toulouse Identifier: NCT03684486    
Other Study ID Numbers: RC31/11/0087
First Posted: September 25, 2018    Key Record Dates
Last Update Posted: July 30, 2020
Last Verified: July 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University Hospital, Toulouse:
bronchial cancer
Additional relevant MeSH terms:
Layout table for MeSH terms
Carcinoma, Bronchogenic
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms, Mesothelial
Bronchial Neoplasms
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Lung Diseases
Respiratory Tract Diseases